Ionis Pharmaceuticals Inc (NASDAQ:IONS)

50.05
Delayed Data
As of Feb 16
 +0.27 / +0.54%
Today’s Change
37.26
Today|||52-Week Range
65.51
-0.50%
Year-to-Date

Today’s Trading

Previous close49.78
Today’s open49.81
Day’s range49.68 - 50.90
Volume497,146
Average volume (3 months)1,095,081
Market cap$6.2B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+2.70%
Earnings growth (this year)+92.74%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)+22.18%
P/E ratio217.6
Price/Sales16.69
Price/Book61.14

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-1.18-0.87%
TSROTESARO Inc-1.03-1.69%
RDYDr.Reddy's Laborator...+0.01+0.03%
GRFSGrifols SA-0.07-0.30%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateMarch 2, 2018
EPS forecast (this quarter)$0.00
Annual revenue (last year)$346.6M
Annual profit (last year)-$86.6M
Net profit margin-24.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Inside Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts